False
August 3, 2026
A previously undisclosed death in China raises questions about gene-editing oversight, deramiocel meets its Phase 3 Duchenne endpoint, and researchers identify a source of CAR NK dysfunction
4 min read
July 31, 2026
Nominations are now open for The Medicine Maker 2026 Innovation Awards, celebrating the latest technologies for drug development and manufacturing
1 min read
July 30, 2026
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
8 min read
July 29, 2026
As product pipelines become more varied, biomanufacturers are rethinking how facilities, data systems and workforce skills support day-to-day operations
6 min read
July 28, 2026
Caidya Executive Chairman Lingshi Tan explains why capital discipline, early clinical execution, and global development strategy are becoming central to biotech success
8 min read
July 27, 2026
Allogeneic CAR T produces durable responses in advanced kidney cancer, the FDA clears a CD22-directed in vivo therapy, and Repligen agrees to acquire BioLife Solutions for $1.5 billion
4 min read
July 27, 2026
AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck
3 min read
July 24, 2026
Industry experts share practical advice for emerging biotech companies navigating development decisions, funding pressures, manufacturing strategy, partner selection, and the path toward commercial readiness
9 min read
July 23, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
False